Mind Medicine (MindMed) Inc.DFTX決算レポート
Definium Therapeutics, Inc., formerly known as MindMed, is a New York-based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, more broadly, psychoplastogenic drugs.
DFTX Q4 2023 Key Financial Metrics
売上高
$906.0K
粗利益
N/A
営業利益
$-22.2M
純利益
$-23.9M
粗利益率
N/A
営業利益率
-2450.8%
純利益率
-2634.0%
前年比成長
-16.1%
EPS
$-0.58
資金フロー
Mind Medicine (MindMed) Inc. Q4 2023 財務サマリー
Mind Medicine (MindMed) Inc. reported revenue of $906.0K (down 16.1% YoY) for Q4 2023, with a net profit of $-23.9M (down 386.7% YoY) (-2634.0% margin). Cost of goods sold was N/A.
主要財務指標
| 総売上高 | $906.0K |
|---|---|
| 純利益 | $-23.9M |
| 粗利益率 | N/A |
| 営業利益率 | -2450.8% |
| 報告期間 | Q4 2023 |
Mind Medicine (MindMed) Inc. 年度売上推移
Mind Medicine (MindMed) Inc. annual revenue history includes year-by-year totals (for example, 2023 revenue was $4.7M). Click any linked year to see what changed vs the prior 10-K.
Mind Medicine (MindMed) Inc. 四半期売上・純利益の履歴
Mind Medicine (MindMed) Inc. quarterly results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| 四半期 | 売上高 | 売上前年比 | 純利益 | 純利益率 |
|---|---|---|---|---|
| Q4 2023 | $906.0K | -16.1% | $-23.9M | -2634.0% |
| Q3 2023 | $1.2M | +223.1% | $-17.9M | -1541.1% |
| Q2 2023 | $1.3M | +1498.8% | $-29.1M | -2222.0% |
| Q1 2023 | $1.3M | +4855.6% | $-24.8M | -1932.6% |
| Q4 2022 | $1.1M | — | $-4.9M | -454.0% |
| Q3 2022 | $360.0K | +662.5% | $-16.5M | -4579.2% |
| Q2 2022 | $82.0K | — | $-17.0M | -20679.3% |
| Q1 2022 | $-27.0K | — | $-18.5M | 68337.0% |
損益計算書
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| 売上高 | $-27000 | $82000 | $360000 | $1.1M | $1.3M | $1.3M | $1.2M | $906000 |
| 前年比成長 | N/A | N/A | 662.5% | N/A | 4855.6% | 1498.8% | 223.1% | -16.1% |
貸借対照表
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| 総資産 | $149.2M | $134.3M | $180.9M | $170.0M | $155.5M | $142.1M | $141.6M | $124.5M |
| 総負債 | $12.4M | $9.8M | $27.3M | $19.1M | $25.2M | $36.1M | $45.6M | $46.4M |
| 株主資本 | $136.8M | $124.5M | $153.6M | $150.9M | $130.3M | $106.0M | $96.0M | $78.1M |
キャッシュフロー
| Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | |
|---|---|---|---|---|---|---|---|---|
| 営業CF | $-12.9M | $-15.1M | $-9.3M | $-12.8M | $-13.3M | $-13.8M | $-16.6M | $-20.6M |